Sabra Healthcare REIT, Inc. (SBRA) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 19, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 3, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SBRA SEC filings page.
Sabra Healthcare REIT, Inc. (SBRA) reported $859.6M in revenue over the twelve months to Jun 30, 2026, up 17.3% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Reported earnings have recovered, but the balance sheet is becoming more debt-dependent while cash generation still funds dividends.
In FY2025, operating cash flow reached$349M versus dividends of$289M . That cash coverage, alongside net income of$156M , suggests distributions were supported by reported operating cash generation rather than accounting profit alone.
The reported bottom line shifted from a net loss of
Debt-to-equity climbed from 0.7x in FY2021 to 0.9x in FY2025, marking a more leveraged capital structure. With total assets at
Financial Health Signals
Scored against REITs for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Sabra Healthcare REIT, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
FFO Margin measures funds from operations against revenue, and funds from operations is net income with property depreciation added back, since a building written down a little further every year on paper is often worth more rather than less. Sabra Healthcare REIT, Inc. scores 67/100 on it among other REITs.
FFO Growth follows the three-year path of funds from operations, which is net income with property depreciation added back. Sabra Healthcare REIT, Inc. scores 83/100 on it among other REITs.
Not available for Sabra Healthcare REIT, Inc., and counted as zero in the overall score.
Not available for Sabra Healthcare REIT, Inc., and counted as zero in the overall score.
AFFO Margin takes funds from operations, subtracts the spending a REIT needs just to keep its properties in working order, and measures what is left against revenue. Sabra Healthcare REIT, Inc. scores 71/100 on it among other REITs.
Dividend coverage measures funds from operations against the dividends actually paid, and a figure above 1 means the payout came out of operations. Sabra Healthcare REIT, Inc. scores 36/100 on it among other REITs.
Sabra Healthcare REIT, Inc. passes 5 of 7 computable financial strength tests (2 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
For every $1 of reported earnings, Sabra Healthcare REIT, Inc. generates $2.24 in operating cash flow ($348.6M OCF vs $155.6M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
Sabra Healthcare REIT, Inc. generated $235.9M in revenue in Q2 2026. This represents an increase of 24.7% from the same quarter a year earlier. Against the prior quarter it is up 6.4%.
Sabra Healthcare REIT, Inc. reported -$25.2M in net income in Q2 2026. This represents a decrease of 138.5% from the same quarter a year earlier. Against the prior quarter it is down 161.6%.
Sabra Healthcare REIT, Inc. earned -$0.10 per diluted share (EPS) in Q2 2026. This represents a decrease of 137.0% from the same quarter a year earlier. Against the prior quarter it is down 162.5%.
Not reported for Q2 2026.
Cash & Balance Sheet
Sabra Healthcare REIT, Inc. held $231.6M in cash against $2.6B in long-term debt as of Q2 2026.
Sabra Healthcare REIT, Inc. paid $0.30 per share in dividends in Q2 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.
Not reported for Q2 2026.
Margins & Returns
Sabra Healthcare REIT, Inc.'s net profit margin was -10.7% in Q2 2026, showing the share of revenue converted to profit. This is down 45.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 29.1 percentage points.
Sabra Healthcare REIT, Inc.'s ROE was -0.9% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 3.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.4 percentage points.
Not reported for Q2 2026.
Not reported for Q2 2026.
Capital Allocation
None of these metrics is reported for Q2 2026.
SBRA Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $235.9M+24.7% | $221.8M+20.8% | $211.9M+16.2% | $190.0M+6.8% | $189.2M+7.4% | $183.5M+10.1% | $182.3M+11.6% | $178.0M+10.1% |
| SG&A Expenses | $16.8M+34.4% | $14.9M+16.8% | $15.9M+22.1% | $12.6M+1.3% | $12.5M-1.8% | $12.7M+7.0% | $13.0M-21.9% | $12.4M+15.3% |
| Interest Expense | $29.8M+8.1% | $28.4M+4.8% | $28.9M+3.1% | $28.9M-1.9% | $27.5M-6.0% | $27.1M-4.6% | $28.1M+0.5% | $29.5M+4.7% |
| Income Tax | $678K+36.4% | $526K+27.4% | $491K+29.2% | $436K+264.5% | $497K+13.7% | $413K-8.8% | $380K-22.9% | -$265K-158.2% |
| Net Income | -$25.2M-138.5% | $40.9M+1.4% | $27.2M-41.7% | $22.5M-24.3% | $65.5M+173.4% | $40.3M+53.5% | $46.7M+172.2% | $29.8M+297.3% |
| EPS (Basic) | -$0.10-135.7% | $0.16-5.9% | $0.10-50.0% | $0.09-30.8% | $0.28+180.0% | $0.17+54.5% | $0.20+185.7% | $0.13+285.7% |
| EPS (Diluted) | -$0.10-137.0% | $0.16-5.9% | $0.11-45.0% | $0.09-30.8% | $0.27+170.0% | $0.17+54.5% | $0.20+185.7% | $0.13+285.7% |
| Diluted Shares (Avg) | 252M+4.7% | 256M+6.5% | N/A | 244M+2.7% | 241M+3.1% | 240M+3.0% | N/A | 237M+2.5% |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA.
SBRA Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.5B+3.5% | $5.6B+6.8% | $5.5B+3.6% | $5.6B+3.7% | $5.3B-0.4% | $5.2B-2.6% | $5.3B-1.5% | $5.4B-0.3% |
| Cash & Equivalents | $231.6M+143.3% | $116.5M+414.4% | $71.5M+18.3% | $200.6M+218.4% | $95.2M+161.5% | $22.7M-62.2% | $60.5M+46.5% | $63.0M+89.5% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $2.8B+5.5% | $2.8B+10.8% | $2.7B+4.2% | $2.7B+4.4% | $2.6B+1.1% | $2.5B-2.9% | $2.6B-0.8% | $2.6B+4.4% |
| Long-Term Debt | $2.6B+5.9% | $2.7B+11.3% | $2.5B+4.6% | $2.6B+4.9% | $2.5B+1.4% | $2.4B-2.8% | $2.4B+0.1% | $2.5B+5.1% |
| Total Equity | $2.8B+1.4% | $2.8B+3.1% | $2.8B+2.9% | $2.8B+2.9% | $2.7B-1.8% | $2.7B-2.3% | $2.7B-2.2% | $2.7B-4.3% |
Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Goodwill, Current Liabilities, Non-Current Liabilities, Retained Earnings.
SBRA Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $85.8M+6.0% | $98.4M+22.5% | $87.4M+9.3% | $100.0M+2.4% | $81.0M+1.0% | $80.3M+52.0% | $80.0M+1.6% | $97.7M+17.3% |
| Depreciation & Amortization | $56.4M+29.4% | $53.1M+22.2% | $51.4M+21.5% | $48.5M+13.6% | $43.6M+4.6% | $43.5M+1.4% | $42.3M-1.3% | $42.7M-1.2% |
| Stock-Based Compensation | N/A | $3.1M+14.3% | N/A | N/A | N/A | $2.7M+7.5% | N/A | N/A |
| Investing Cash Flow | $86.5M+291.7% | -$105.1M-539.1% | -$116.5M-727.9% | -$199.8M-250.4% | -$45.1M+21.2% | -$16.4M-24.3% | $18.6M+130.0% | -$57.0M-195.2% |
| Financing Cash Flow | -$57.4M-256.2% | $52.1M+151.5% | -$100.9M+0.1% | $206.2M+1577.4% | $36.7M+179.1% | -$101.2M-400.5% | -$101.0M-978.3% | -$14.0M+89.8% |
| Dividends Paid | $75.7M+6.0% | $75.7M+6.0% | $74.8M+5.4% | $71.9M+2.4% | $71.4M+2.8% | $71.4M+2.8% | $71.0M+2.3% | $70.3M+1.3% |
Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Share Buybacks.
SBRA Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Net Margin | -10.7%-45.3pp | 18.4%-3.5pp | 12.8%-12.8pp | 11.9%-4.9pp | 34.6%+21.0pp | 22.0%+6.2pp | 25.6%+15.1pp | 16.7%+26.1pp |
| Return on Equity | -0.9%-3.3pp | 1.5%0.0pp | 1.0%-0.7pp | 0.8%-0.3pp | 2.4%+1.6pp | 1.5%+0.5pp | 1.7%+1.1pp | 1.1%+1.6pp |
| Return on Assets | -0.5%-1.7pp | 0.7%0.0pp | 0.5%-0.4pp | 0.4%-0.1pp | 1.2%+0.8pp | 0.8%+0.3pp | 0.9%+0.6pp | 0.6%+0.8pp |
| Debt-to-Equity | 0.950.0x | 0.96+0.1x | 0.900.0x | 0.920.0x | 0.910.0x | 0.890.0x | 0.880.0x | 0.90+0.1x |
| Asset Turnover | 0.040.0x | 0.040.0x | 0.040.0x | 0.030.0x | 0.040.0x | 0.040.0x | 0.030.0x | 0.030.0x |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Sabra Healthcare REIT, Inc. SBRA | FY2025 | $774.6M | $155.6M | 20.1% | $4.9B | 43/100 |
| Healthcare Realty Trust Incorporated HR | FY2025 | $1.2B | -$249.5M | -21.1% | $6.0B | 22/100 |
| National Health Investors NHI | FY2025 | $375.6M | $142.2M | 37.9% | $3.3B | 36/100 |
| CareTrust REIT, Inc CTRE | FY2025 | $476.4M | $320.5M | 67.3% | $8.6B | 58/100 |
| American Healthcare REIT, Inc. AHR | FY2025 | $2.3B | $70.8M | 3.1% | $11.6B | 53/100 |
| Medical Properties Trust, Inc. MPW | FY2025 | $972.0M | -$277.0M | -28.5% | $3.0B | 2/100 |
Where Sabra Healthcare REIT, Inc. Ranks
Frequently Asked Questions
What is Sabra Healthcare REIT, Inc.'s annual revenue?
Sabra Healthcare REIT, Inc. (SBRA) reported $774.6M in total revenue for fiscal year 2025. This represents a 10.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Sabra Healthcare REIT, Inc.'s revenue growing?
Sabra Healthcare REIT, Inc. (SBRA) revenue grew by 10.2% year-over-year, from $703.2M to $774.6M in fiscal year 2025.
Is Sabra Healthcare REIT, Inc. profitable?
Yes, Sabra Healthcare REIT, Inc. (SBRA) reported a net income of $155.6M in fiscal year 2025, with a net profit margin of 20.1%.
How much debt does Sabra Healthcare REIT, Inc. have?
As of fiscal year 2025, Sabra Healthcare REIT, Inc. (SBRA) had $71.5M in cash and equivalents against $2.5B in long-term debt.
What is Sabra Healthcare REIT, Inc.'s net profit margin?
Sabra Healthcare REIT, Inc. (SBRA) had a net profit margin of 20.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does Sabra Healthcare REIT, Inc. pay dividends?
Yes, Sabra Healthcare REIT, Inc. (SBRA) paid $1.20 per share in dividends during fiscal year 2025.
What is Sabra Healthcare REIT, Inc.'s return on equity (ROE)?
Sabra Healthcare REIT, Inc. (SBRA) has a return on equity of 5.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Sabra Healthcare REIT, Inc.'s operating cash flow?
Sabra Healthcare REIT, Inc. (SBRA) generated $348.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Sabra Healthcare REIT, Inc.'s total assets?
Sabra Healthcare REIT, Inc. (SBRA) had $5.5B in total assets as of fiscal year 2025, including both current and long-term assets.
What is Sabra Healthcare REIT, Inc.'s debt-to-equity ratio?
Sabra Healthcare REIT, Inc. (SBRA) had a debt-to-equity ratio of 0.90 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Sabra Healthcare REIT, Inc.'s return on assets (ROA)?
Sabra Healthcare REIT, Inc. (SBRA) had a return on assets of 2.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Sabra Healthcare REIT, Inc.'s P/E ratio?
Sabra Healthcare REIT, Inc. (SBRA) trades at 74.5x earnings, its market capitalization divided by net income of $65.4M net income, trailing 12 months to June 30, 2026. The market capitalization is $4.9B as of Oct 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Sabra Healthcare REIT, Inc.'s price-to-sales ratio?
Sabra Healthcare REIT, Inc. (SBRA) trades at 5.7x sales, its market capitalization divided by revenue of $859.6M revenue, trailing 12 months to June 30, 2026. The market capitalization is $4.9B as of Oct 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Sabra Healthcare REIT, Inc.'s Piotroski F-Score?
Sabra Healthcare REIT, Inc. (SBRA) has a Piotroski F-Score of 5 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Sabra Healthcare REIT, Inc.'s earnings high quality?
Sabra Healthcare REIT, Inc. (SBRA) has an earnings quality ratio of 2.24x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Sabra Healthcare REIT, Inc.?
Sabra Healthcare REIT, Inc. (SBRA) scores 43 out of 100 on our Financial Health Score, indicating moderate standing within its REITs peer group. The score is a 0-100 composite of six dimensions (FFO Margin, FFO Growth, Leverage, Interest Cov., AFFO Margin, Dividend Cov.), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.